Imatinib gives impressive long-term survival in CML patients

被引：0
|
作者：
不详
机构：
来源：
BRITISH JOURNAL OF HOSPITAL MEDICINE | 2009年 / 70卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：71 / 71
页数：1
相关论文
共 50 条
  • [1] Long-term imatinib therapy promotes bone formation in CML patients
    Fitter, Stephen
    Dewar, Andrea L.
    Kostakis, Panagiota
    To, L. Bik
    Hughes, Timothy P.
    Roberts, Marion M.
    Lynch, Kevin
    Vernon-Roberts, Barrie
    Zannettino, Andrew C. W.
    BLOOD, 2008, 111 (05) : 2538 - 2547
  • [2] Reply: The long-term response to imatinib treatment of CML
    Michor, F.
    BRITISH JOURNAL OF CANCER, 2007, 96 (04) : 679 - 680
  • [3] Reply: The long-term response to imatinib treatment of CML
    F Michor
    British Journal of Cancer, 2007, 96 : 679 - 680
  • [4] Correlation Between Imatinib Trough Concentration and Long-Term Tolerability in CML Patients
    Masuko, Masayoshi
    Furukawa, Tatsuo
    Tanaka, Toyoyuki
    Miyakoshi, Syukuko
    Kozakai, Takashi
    Fuse, Kyoko
    Shibasaki, Yasuhiko
    Takai, Kazue
    Seki, Yoshinobu
    Kobayashi, Masashi
    Nagai, Koichi
    Takahashi, Hoyu
    Kishi, Kenji
    Narita, Miwako
    Takahashi, Masuhiro
    Koike, Tadashi
    Shibata, Akira
    BLOOD, 2012, 120 (21)
  • [5] The safety profile of imatinib in CML and GIST: long-term considerations
    Thanopoulou, Eirini
    Judson, Ian
    ARCHIVES OF TOXICOLOGY, 2012, 86 (01) : 1 - 12
  • [6] The safety profile of imatinib in CML and GIST: long-term considerations
    Eirini Thanopoulou
    Ian Judson
    Archives of Toxicology, 2012, 86 : 1 - 12
  • [7] Imatinib Long Term Effects (ILTE) Study: An International Study to Evaluate Long-Term Effects in CML Patients.
    Kim, Dong-Wook
    Antolini, Laura
    Mahon, Francois-Xavier
    Guilhot, Francois
    Deininger, Michael
    Saglio, Giuseppe
    Nagler, Arnon
    Rambaldi, Alessandro
    Morra, Enrica
    Abruzzese, Elisabetta
    Di Raimondo, Francesco
    le Coutre, Philipp
    Monroy, Rafael Hurtado
    Durosinmi, Muheez A.
    Leeksma, Onno
    Pane, Fabrizio
    Miglietta, Stefania
    Kweon, Il-Young
    Reiffers, Josy
    Valsecchi, Maria Grazia
    Gambacorti-Passerini, Carlo
    BLOOD, 2009, 114 (22) : 865 - 866
  • [8] Excellent Outcome and Good Tolerability of Long-Term Imatinib in Patients with Chronic Myeloid Leukemia (CML)
    Claudiani, Simone
    Gupta, Nikhita
    Baik, Ji Soo
    Deplano, Simona
    Palanicawander, Renuka
    Gerrard, Gareth
    Reid, Alistair G.
    Szydlo, Richard M.
    Milojkovic, Dragana
    Foroni, Letizia
    Apperley, Jane F.
    BLOOD, 2015, 126 (23)
  • [9] Long-term survival of patients with CML: The role of hematologic and cytogenetic response.
    Hasford, J
    Pfirrman, M
    Shepherd, P
    Guilhot, F
    Hehlmann, R
    Baccarani, M
    Mahon, FX
    Kluin-Nelemans, HC
    Ohnishi, K
    Steegmann, JL
    Thaler, J
    Delannoy, A
    Kloke, O
    BLOOD, 2002, 100 (11) : 785A - 785A
  • [10] PROJECTING THE LONG-TERM SURVIVAL OF NEWLY DIAGNOSED PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) IN CHRONIC PHASE (CP) RECEIVING NILOTINIB OR IMATINIB
    Botteman, F.
    Stephens, J.
    Coombs, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 348 - 348
12345